Jacobs Levy Equity Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-183,867
| Closed | -$351K | – | 935 |
|
|
2022
Q3 | $351K | Buy |
+183,867
| New | +$351K | ﹤0.01% | 874 |
|
|
2022
Q2 | – | Sell |
-55,713
| Closed | -$166K | – | 984 |
|
|
2022
Q1 | $166K | Hold |
55,713
| – | – | ﹤0.01% | 970 |
|
|
2021
Q4 | $217K | Buy |
+55,713
| New | +$217K | ﹤0.01% | 931 |
|
|
2019
Q3 | – | Sell |
-30,593
| Closed | -$64K | – | 910 |
|
|
2019
Q2 | $64K | Buy |
30,593
+8,797
| +40% | +$18.4K | ﹤0.01% | 926 |
|
|
2019
Q1 | $78K | Buy |
+21,796
| New | +$78K | ﹤0.01% | 939 |
|